The Algorithm That's Fixing Biopesticide R&D

AI and machine learning are slashing biopesticide discovery timelines and pushing hit rates from under 2% to above 30%

26 Oct 2025

Biopesticide researchers once combed through microbial libraries with roughly the same odds as finding a needle in a haystack: a hit rate of about 1.5%. That figure has now risen to above 30% for herbicidal targets, and above 38% for aquatic biocontrol candidates, thanks to artificial intelligence applied to genomic datasets. The change in odds is not modest. It is, in the vocabulary of industrial science, transformational.

A study published in Frontiers in Insect Science in late 2025 by Pamela Marrone of Invasive Species Corporation in Davis, California, provides the most rigorous account yet of how AI and machine learning are reshaping biopesticide discovery. Ms Marrone's research documents how full genome sequencing allows scientists to identify the specific genes responsible for producing pesticidal metabolites, giving fermentation engineers a level of precision that empirical screening could never provide.

The commercial case for such technology was bolstered when Syngenta, one of the world's largest agrochemical firms, announced a partnership with TraitSeq, an AI company spun out of the Earlham Institute. The collaboration applies machine learning to large-scale omics datasets drawn from Syngenta's crop biology library, with the aim of identifying molecular biomarkers: cellular signals that reveal how a plant responds to a biostimulant under drought or heat stress. Camilla Corsi, Syngenta's head of crop protection research and development, described the arrangement as enabling the company to "develop next-generation sustainable solutions faster."

The broader significance lies not in any single discovery but in what these developments suggest about the structure of agricultural R&D. Genomics, machine learning, and advanced fermentation science are converging to replace slow, labour-intensive screening with faster, data-driven pipelines. For a sector historically constrained by the length and cost of product development cycles, that matters.

What remains unresolved is whether the regulatory and commercial infrastructure surrounding biopesticides can keep up. Compressing discovery timelines is only useful if approval pathways and supply chains move at a comparable pace. The algorithm, for now, may be outrunning the system it feeds.